Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Stephen Dreskin and Jenny Stitt.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.940 |
|
|
|
-
Stitt JM, Dzieciatkowska M, Edwards MG, Hansen K, Hedlund G, Dreskin SC. The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non-responders. Clin Exp Allergy. 2018 07; 48(7):898-901.
Score: 0.597
-
Stitt JM, Dreskin SC. The potential role of omalizumab in the treatment of chronic urticaria. Immunotherapy. 2014; 6(6):691-7.
Score: 0.440
-
Stitt JM, Dreskin SC. Urticaria and autoimmunity: where are we now? Curr Allergy Asthma Rep. 2013 Oct; 13(5):555-62.
Score: 0.433
-
Keller L, Stitt JM, Dreskin SC. Total IgE as a biomarker of response to omalizumab in chronic urticaria: A prospective study. Ann Allergy Asthma Immunol. 2025 Aug 31.
Score: 0.247
-
Keller L, Perera EK, Bindon B, Khatiwada A, Stitt JM, Dreskin SC. Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis. Allergy Asthma Proc. 2024 Mar 01; 45(2):97-99.
Score: 0.223